Oak Street Health (NYSE:OSH) Lifted to Hold at Zacks Investment Research

Oak Street Health (NYSE:OSHGet Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a note issued to investors on Thursday, Zacks.com reports.

According to Zacks, “Oak Street Health Inc. is a primary care centers for adults on Medicare. It operates principally in Illinois, Michigan, Indiana, Pennsylvania, Ohio, Rhode Island, North Carolina, Tennessee and Texas. Oak Street Health Inc. is based in Chicago, United States. “

Other equities analysts have also issued reports about the stock. Cowen raised shares of Oak Street Health from a “market perform” rating to an “outperform” rating and upped their target price for the stock from $25.00 to $30.00 in a research note on Thursday, March 17th. Truist Financial cut their price target on shares of Oak Street Health from $45.00 to $34.00 in a research report on Wednesday, January 19th. UBS Group assumed coverage on shares of Oak Street Health in a research report on Wednesday, April 20th. They set a “neutral” rating and a $26.00 price target on the stock. The Goldman Sachs Group cut their price target on shares of Oak Street Health from $68.00 to $37.00 and set a “buy” rating on the stock in a research report on Monday, March 21st. Finally, Piper Sandler cut their price target on shares of Oak Street Health from $47.00 to $43.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 2nd. Five research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $39.79.

Shares of NYSE OSH opened at $16.24 on Thursday. The firm has a market cap of $3.92 billion, a PE ratio of -8.20 and a beta of 2.41. The company has a current ratio of 1.79, a quick ratio of 1.79 and a debt-to-equity ratio of 16.10. Oak Street Health has a 1-year low of $13.29 and a 1-year high of $65.22. The company has a fifty day moving average price of $22.19 and a 200 day moving average price of $25.61.

Oak Street Health (NYSE:OSHGet Rating) last announced its earnings results on Tuesday, May 3rd. The company reported ($0.43) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.04). The company had revenue of $513.80 million during the quarter, compared to analyst estimates of $506.82 million. Oak Street Health had a negative return on equity of 413.94% and a negative net margin of 26.82%. Oak Street Health’s revenue for the quarter was up 73.2% on a year-over-year basis. During the same period in the previous year, the company posted ($0.29) earnings per share. Equities research analysts forecast that Oak Street Health will post -2.19 EPS for the current year.

In related news, COO Brian Clem sold 15,000 shares of the company’s stock in a transaction dated Thursday, March 3rd. The shares were sold at an average price of $21.35, for a total value of $320,250.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Geoffrey M. Price sold 60,000 shares of the company’s stock in a transaction dated Tuesday, April 5th. The shares were sold at an average price of $26.56, for a total transaction of $1,593,600.00. Following the completion of the transaction, the insider now owns 3,871,377 shares in the company, valued at approximately $102,823,773.12. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 275,000 shares of company stock worth $6,529,450. 11.40% of the stock is owned by insiders.

Large investors have recently made changes to their positions in the business. Baird Financial Group Inc. grew its position in shares of Oak Street Health by 9.6% during the 4th quarter. Baird Financial Group Inc. now owns 28,947 shares of the company’s stock worth $959,000 after purchasing an additional 2,537 shares in the last quarter. CWM LLC acquired a new position in shares of Oak Street Health during the 4th quarter worth approximately $851,000. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its position in shares of Oak Street Health by 32.4% during the 4th quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 27,078 shares of the company’s stock worth $934,000 after purchasing an additional 6,630 shares in the last quarter. Royal Bank of Canada grew its position in shares of Oak Street Health by 2.9% during the 3rd quarter. Royal Bank of Canada now owns 627,796 shares of the company’s stock worth $26,701,000 after purchasing an additional 17,447 shares in the last quarter. Finally, Blueshift Asset Management LLC acquired a new stake in shares of Oak Street Health during the 3rd quarter worth approximately $695,000. Hedge funds and other institutional investors own 91.42% of the company’s stock.

About Oak Street Health (Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.

See Also

Get a free copy of the Zacks research report on Oak Street Health (OSH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.